16-week CR rate |
MA group |
LNG-IUS group |
MA+LNG-IUS group |
Pa
|
Pb
|
Pc
|
Age ≥ 30 years |
25.0% (7/28) |
48.4% (15/31) |
32.3% (10/31) |
0.154 |
0.064 |
0.539 |
Age < 30 years |
26.7% (4/15) |
40.0% (6/15) |
50.0% (6/12) |
0.455 |
0.439 |
0.257 |
IR* |
27.3% (3/11) |
33.3% (3/9) |
21.4% (3/14) |
0.887 |
1.000 |
1.000 |
Non-IR* |
25.0% (8/32) |
48.6% (18/37) |
44.8% (13/29) |
0.109 |
0.043 |
0.104 |
BMI ≥ 28 kg/m2
|
0.0% (0/12) |
41.7% (5/12) |
14.3%
(2/14) |
0.030 |
0.037 |
0.483 |
BMI < 28 kg/m2
|
35.5% (11/31) |
47.1%
(16/34) |
48.3% (14/29) |
0.534 |
0.344 |
0.315 |
MS |
23.5% (4/17) |
42.1% (8/19) |
29.4% (5/17) |
0.472 |
0.238 |
1.000 |
Non-MS |
26.9% (7/26) |
48.1% (13/27) |
42.3% (11/26) |
0.265 |
0.111 |
0.244 |
Hypertension |
25.0% (2/8) |
100.0% (3/3) |
10.0% (1/10) |
0.013 |
0.061 |
0.559 |
Non-hypertension |
25.7% (9/35) |
41.9% (18/43) |
45.5% (15/33) |
0.192 |
0.136 |
0.089 |
Diabetes |
25.0% (1/4) |
66.7% (2/3) |
0.0% (0/3) |
0.400 |
0.486 |
1.000 |
Non-Diabetes |
25.6% (10/39) |
44.2% (19/43) |
40.0% (16/40) |
0.195 |
0.079 |
0.174 |